Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baque, S.
Right arrow Articles by Gomez-Foix, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baque, S.
Right arrow Articles by Gomez-Foix, A. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 47, Issue 9 1392-1398, Copyright © 1998 by American Diabetes Association


ARTICLES

Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage

S Baque, E Montell, JJ Guinovart, CB Newgard and AM Gomez-Foix
Department de Bioquimica i Biologia Molecular, Universitat de Barcelona, Spain.

Insulin resistance, as is found in skeletal muscle of individuals with obesity and NIDDM, appears to involve a reduced capacity of the hormone to stimulate glucose uptake and/or phosphorylation. The glucose phosphorylation step, as catalyzed by hexokinase II, has been described as rate limiting for glucose disposal in muscle, but overexpression of this enzyme under control of a muscle-specific promoter in transgenic mice has had limited metabolic impact. In the current study, we investigated in a cultured muscle model whether expression of glucokinase, which in contrast to hexokinase II is not inhibited by glucose-6-phosphate (G-6-P), would have a pronounced metabolic impact. We used a recombinant adenovirus containing the cDNA-encoding rat liver glucokinase (AdCMV-GKL) to increase the glucose phosphorylating activity in cultured human muscle cells by fourfold. G-6-P levels increased in AdCMV-GKL-treated cells in a glucose concentration-dependent manner over the range of 1-30 mmol/l, whereas the much smaller increases in G-6-P in control cells were maximal at glucose concentrations <5 mmol/l. Further, cells expressing glucokinase accumulated 17 times more 2-deoxyglucose-6-phosphate than control cells. In AdCMV-GKL-treated cells, the time-dependent rise in G-6-P correlated with an increase in the activity ratio of glycogen synthase. AdCMV-GKL-treated cells also exhibited a 2.5- to 3-fold increase in glycogen content and a four- to fivefold increase in glycolytic flux, proportional to the increase in glucose phosphorylating capacity. All of these observations were made in the absence of insulin. Thus we concluded that expression of glucokinase in cultured human muscle cells results in proportional increases in insulin-independent glucose disposal, and that muscle glucose storage and utilization becomes controlled in a glucose concentration-dependent manner in AdCMV-GKL-treated cells. These results encourage testing whether delivery of glucokinase to muscle in vivo has an impact on glycemic control, which could be a method for circumventing the failure of insulin to stimulate glucose uptake and/or phosphorylation in muscle normally in insulin-resistant subjects.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. R. Gomis, E. Cid, M. Garcia-Rocha, J. C. Ferrer, and J. J. Guinovart
Liver Glycogen Synthase but Not the Muscle Isoform Differentiates between Glucose 6-Phosphate Produced by Glucokinase or Hexokinase
J. Biol. Chem., June 21, 2002; 277(26): 23246 - 23252.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. C. JIMÉNEZ-CHILLARÓN, C. B. NEWGARD, and A. M. GÓMEZ-FOIX
Increased glucose disposal induced by adenovirus-mediated transfer of glucokinase to skeletal muscle in vivo
FASEB J, December 1, 1999; 13(15): 2153 - 2160.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Ardehali, R. L. Printz, R. R. Whitesell, J. M. May, and D. K. Granner
Functional Interaction between the N- and C-terminal Halves of Human Hexokinase II
J. Biol. Chem., June 4, 1999; 274(23): 15986 - 15989.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Lerin, E. Montell, H. K. Berman, C. B. Newgard, and A. M. Gomez-Foix
Overexpression of Protein Targeting to Glycogen in Cultured Human Muscle Cells Stimulates Glycogen Synthesis Independent of Glycogen and Glucose 6-Phosphate Levels
J. Biol. Chem., December 15, 2000; 275(51): 39991 - 39995.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.